These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Biologic interaction of prostaglandin, thromboxane and prostacyclin: potential clinical applications. Bell TG; Smith WL; Oxender WD J Environ Pathol Toxicol Oncol; 1986; 6(3-4):191-201. PubMed ID: 3012063 [TBL] [Abstract][Full Text] [Related]
8. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. Moncada S; Vane JR N Engl J Med; 1979 May; 300(20):1142-7. PubMed ID: 219340 [No Abstract] [Full Text] [Related]
9. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology]. Baluda VP; Sushkevich GN; Lukoianova TI Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418 [No Abstract] [Full Text] [Related]
10. [Determination of TXA2 formed by blood platelets and PGX formed by blood vessels and formation of thrombi]. Srivastava KC Ugeskr Laeger; 1977 Nov; 139(47):2815-6. PubMed ID: 339456 [No Abstract] [Full Text] [Related]
11. Glucocorticoids in the management of vasculitis--a double edged sword? Conn DL; Tompkins RB; Nichols WL J Rheumatol; 1988 Aug; 15(8):1181-3. PubMed ID: 3141621 [No Abstract] [Full Text] [Related]
12. [Prostaglandins and ischemic cardiopathy]. Patrono C; De Caterina R; Maseri A G Ital Cardiol; 1980; 10(10):1371-82. PubMed ID: 7016653 [No Abstract] [Full Text] [Related]
13. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Vincent JE; Zijlstra FJ; van Vliet H Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279 [No Abstract] [Full Text] [Related]
14. Biological properties of prostacyclin-thromboxane system. Blaskó G Ther Hung; 1984; 32(2):45-51. PubMed ID: 6443751 [No Abstract] [Full Text] [Related]
15. [Platelet aggregation, thrombosis formation and prostaglandins]. Higashihara M; Kume S Nihon Rinsho; 1985 Mar; 43(3):555-62. PubMed ID: 3159919 [No Abstract] [Full Text] [Related]
16. Thromboxane and prostacyclin: implications for function and disease of the vasculature. McGiff JC Adv Intern Med; 1980; 25():199-216. PubMed ID: 6987841 [No Abstract] [Full Text] [Related]
17. Hemostasis, thrombosis, and thromboembolic disorders. The role of arachidonic acid metabolites in platelet-vessel wall interactions. Harlan JM; Harker LA Med Clin North Am; 1981 Jul; 65(4):855-80. PubMed ID: 6792433 [No Abstract] [Full Text] [Related]
18. The role of prostacyclin in vascular tissue. Moncada S; Vane JR Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463 [TBL] [Abstract][Full Text] [Related]
19. Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981. Vane JR J Endocrinol; 1982 Nov; 95(2):3P-43P. PubMed ID: 6816886 [No Abstract] [Full Text] [Related]
20. [Mechanisms of action of prostaglandins on the thrombocyte-vascular wall system]. Gabrielian ES; Akopov SE; Badzhinian SA Vestn Akad Med Nauk SSSR; 1984; (11):63-8. PubMed ID: 6099016 [No Abstract] [Full Text] [Related] [Next] [New Search]